ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736161; 2) Community: the network communities that were significantly associated with the response to NSC 736161; 3) Molecule: the relationships between components within communities and NSC 736161; 4) MDR: the compounds that were significantly associated with the NSC 736161.

NSC Compound Enrichment Correlation
NSC 758670 TANNIC ACID 0.00640068043275774 0.13312186
NSC 642311 Null 0.00640068043275779 0.25075059
NSC 646098 Null 0.00640068043275779 -0.089400545
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.00640068043275779 -0.18781869
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.00640068043275779 0.073913412
NSC 756173 GSK326090A 0.00648124190744027 0.27559857
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00648124190744032 0.11633009
NSC 755464 Null 0.00671035899671664 0.37753333
NSC 668488 Null 0.00671035899671669 0.30982356
NSC 675774 Null 0.00671035899671669 0.16544681
Total:63  Current:9    [First] [Prev] [Next] [Last]